Chemed' VITAS Continues to Build Momentum, RBC Says

MT Newswires Live04-28

Chemed's (CHE) VITAS unit continues to build its momentum, driving a Q1 beat and a "rare" post-Q1 guidance raise for the company, RBC Capital Markets said in a Monday note.

"We remain encouraged by VITAS momentum in Florida's new markets, where the company has added meaningful Medicare Cap cushion, significantly limiting cap limitation risk this year," the report said.

Chemed operates VITAS, a provider of end-of-life care, and Roto-Rooter, a plumbing and drain cleaning services provider.

The report said a higher mix of paid leads at Roto-Rooter continues to pressure its margins.

"We remain cautious on Roto-Rooter, where structural marketing

cost headwinds persist and macro risk looms," the note said.

RBC raised its price target to $436 from $422 while keeping its sector perform rating.

Price: 420.03, Change: -1.09, Percent Change: -0.26

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment